Author:
Gandini Sara,Massi Daniela,Mandalà Mario
Reference56 articles.
1. Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors;Akbay;Cancer Discov.,2013
2. Atkinson V., Ascierto P.A., Long G.V., Brady B., Dutriaux C., Maio M., et al., 2015. Two-year Survival and Safety Update in Patients With Treatment-naïve Advanced Melanoma Receiving Nivolumab or Dacarbazine in CheckMate 066, SMR.
3. Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer;Azuma;Ann. Oncol.,2014
4. Innate vs: adaptive: pD-L1-mediated immune resistance by melanoma;Berry;Oncoimmunology,2015
5. Differential expression of PD-L1 between primary and metastatic sites in clear-cell renal cell carcinoma;Callea;Cancer Immunol. Res.,2015
Cited by
293 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献